Status:

NOT_YET_RECRUITING

Harnessing Optimism and Perseverance in the Face of Long COVID-Español

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Conditions:

Post-Acute COVID-19 Syndrome

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, ...

Detailed Description

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, developed by Drs. Eric Watson (PI) and Amelia Hicks (co-I), is a 12-week online group therapy program tailored spe...

Eligibility Criteria

Inclusion

  • Age 18 years or older.
  • Speaks and understands Spanish at a level that allows active participation in group-based study procedures.
  • Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms.
  • Ability to participate in group sessions either in-person or via telehealth (Zoom).
  • Willingness and capacity to provide informed consent.

Exclusion

  • Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention).
  • Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions.
  • Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations.
  • Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms.

Key Trial Info

Start Date :

November 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT07216040

Start Date

November 1 2025

End Date

April 1 2026

Last Update

October 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brain Injury Research Center

New York, New York, United States, 10029